Linked Data API

Show Search Form

Search Results

1657697
star this property registered interest false more like this
star this property date less than 2023-09-04more like thismore than 2023-09-04
unstar this property answering body
Department of Health and Social Care remove filter
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care more like this
star this property hansard heading National Institute for Health and Care Excellence remove filter
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, whether he has held discussions with the National Institute for Health and Care Excellence on the adequacy of the single technology appraisal pathway for the assessment of (a) innovative technologies and (b) advanced therapy medicinal products. more like this
star this property tabling member constituency Strangford more like this
star this property tabling member printed
Jim Shannon more like this
star this property type
WrittenParliamentaryQuestion
star this property uin 197395 remove filter
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2023-09-11more like thismore than 2023-09-11
star this property answer text <p>The Department regularly meets with the National Institute for Health and Care Excellence (NICE) to discuss a range of issues. NICE’s technology appraisal programme has been proven to be suitable for the assessment of innovative medicines and advanced therapy medicinal products (ATMPs) where companies are able to price their products in a way that represents value to the taxpayer.</p><p>NICE has recommended several ATMPs through its technology appraisal programme that are now available to patients in the National Health Service. NICE concluded a review of its methods and processes for health technology evaluation in January 2022 and has introduced changes that ensure that its appraisal processes are suitable for emerging new medicines, including a broader severity modifier and changes to better respond to uncertainty.</p> more like this
star this property answering member constituency Colchester more like this
star this property answering member printed Will Quince more like this
star this property question first answered
less than 2023-09-11T13:30:18.367Zmore like thismore than 2023-09-11T13:30:18.367Z
star this property answering member
4423
star this property label Biography information for Will Quince more like this
star this property tabling member
4131
star this property label Biography information for Jim Shannon more like this